86 related articles for article (PubMed ID: 12221644)
1. Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcoma.
Witlox MA; Van Beusechem VW; Grill J; Haisma HJ; Schaap G; Bras J; Van Diest P; De Gast A; Curiel DT; Pinedo HM; Gerritsen WR; Wuisman PI
J Gene Med; 2002; 4(5):510-6. PubMed ID: 12221644
[TBL] [Abstract][Full Text] [Related]
2. Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule.
Hemminki A; Dmitriev I; Liu B; Desmond RA; Alemany R; Curiel DT
Cancer Res; 2001 Sep; 61(17):6377-81. PubMed ID: 11522629
[TBL] [Abstract][Full Text] [Related]
3. Production of an EGFR targeting molecule from a conditionally replicating adenovirus impairs its oncolytic potential.
Hemminki A; Wang M; Hakkarainen T; Desmond RA; Wahlfors J; Curiel DT
Cancer Gene Ther; 2003 Aug; 10(8):583-8. PubMed ID: 12872139
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cells.
Bonner JA; Buchsbaum DJ; Rogers BE; Grizzle WE; Trummell HQ; Curiel DT; Fiveash JB; Ove R; Raisch KP
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):950-8. PubMed ID: 14967455
[TBL] [Abstract][Full Text] [Related]
5. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.
Wesseling JG; Bosma PJ; Krasnykh V; Kashentseva EA; Blackwell JL; Reynolds PN; Li H; Parameshwar M; Vickers SM; Jaffee EM; Huibregtse K; Curiel DT; Dmitriev I
Gene Ther; 2001 Jul; 8(13):969-76. PubMed ID: 11438831
[TBL] [Abstract][Full Text] [Related]
6. Targeting of adenoviral vectors through a bispecific single-chain antibody.
Haisma HJ; Grill J; Curiel DT; Hoogeland S; van Beusechem VW; Pinedo HM; Gerritsen WR
Cancer Gene Ther; 2000 Jun; 7(6):901-4. PubMed ID: 10880021
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus receptors: implications for tropism, treatment and targeting.
Arnberg N
Rev Med Virol; 2009 May; 19(3):165-78. PubMed ID: 19367611
[TBL] [Abstract][Full Text] [Related]
8. Signaling antibodies complexed with adenovirus circumvent CAR and integrin interactions and improve gene delivery.
Li E; Brown SL; Von Seggern DJ; Brown GB; Nemerow GR
Gene Ther; 2000 Sep; 7(18):1593-9. PubMed ID: 11021598
[TBL] [Abstract][Full Text] [Related]
9. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids.
Grill J; Van Beusechem VW; Van Der Valk P; Dirven CM; Leonhart A; Pherai DS; Haisma HJ; Pinedo HM; Curiel DT; Gerritsen WR
Clin Cancer Res; 2001 Mar; 7(3):641-50. PubMed ID: 11297260
[TBL] [Abstract][Full Text] [Related]
10. Chemogene therapy: osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model.
Cheon J; Ko SC; Gardner TA; Shirakawa T; Gotoh A; Kao C; Chung LW
Cancer Gene Ther; 1997; 4(6):359-65. PubMed ID: 9408606
[TBL] [Abstract][Full Text] [Related]
11. Coxsackievirus and adenovirus receptor expression on primary osteosarcoma specimens and implications for gene therapy with recombinant adenoviruses.
Graat HC; Wuisman PI; van Beusechem VW; Carette JE; Gerritsen WR; Bras J; Schaap GR; Kaspers GJ; Ogose A; Gu W; Kawashima H; Hotta T
Clin Cancer Res; 2005 Mar; 11(6):2445-7; author reply 2447-8. PubMed ID: 15788696
[No Abstract] [Full Text] [Related]
12. Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma.
Geoerger B; van Beusechem VW; Opolon P; Morizet J; Laudani L; Lecluse Y; Barrois M; Idema S; Grill J; Gerritsen WR; Vassal G
J Gene Med; 2005 May; 7(5):584-94. PubMed ID: 15651070
[TBL] [Abstract][Full Text] [Related]
13. Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity.
Krasnykh V; Dmitriev I; Navarro JG; Belousova N; Kashentseva E; Xiang J; Douglas JT; Curiel DT
Cancer Res; 2000 Dec; 60(24):6784-7. PubMed ID: 11156365
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome.
Kersting C; Gebert C; Agelopoulos K; Schmidt H; van Diest PJ; Juergens H; Winkelmann W; Kevric M; Gosheger G; Brandt B; Bielack S; Buerger H
Clin Cancer Res; 2007 May; 13(10):2998-3005. PubMed ID: 17505002
[TBL] [Abstract][Full Text] [Related]
15. Assessment of CAR- or CD46-dependent adenoviral vector-mediated TRAIL gene therapy in clinical adenocarcinoma lung cancer cells.
Wang Y; Ma L; Wang S; Bao Y; Ni C; Guan N; Zhao J; Fan X
Oncology; 2009; 77(6):366-77. PubMed ID: 20068366
[TBL] [Abstract][Full Text] [Related]
16. FGF2-targeted adenoviral vectors for systemic and local disease.
Sosnowski BA; Gu DL; D'Andrea M; Doukas J; Pierce GF
Curr Opin Mol Ther; 1999 Oct; 1(5):573-9. PubMed ID: 11249664
[TBL] [Abstract][Full Text] [Related]
17. Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases.
Worth LL; Jia SF; Zhou Z; Chen L; Kleinerman ES
Clin Cancer Res; 2000 Sep; 6(9):3713-8. PubMed ID: 10999765
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor.
Cristiano RJ; Roth JA
Cancer Gene Ther; 1996; 3(1):4-10. PubMed ID: 8785711
[TBL] [Abstract][Full Text] [Related]
19. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer.
Miller CR; Buchsbaum DJ; Reynolds PN; Douglas JT; Gillespie GY; Mayo MS; Raben D; Curiel DT
Cancer Res; 1998 Dec; 58(24):5738-48. PubMed ID: 9865732
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin.
Ganjavi H; Gee M; Narendran A; Parkinson N; Krishnamoorthy M; Freedman MH; Malkin D
Cancer Gene Ther; 2006 Apr; 13(4):415-9. PubMed ID: 16211088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
